Dare Bioscience
DARE
34 hedge funds and large institutions have $22.3M invested in Dare Bioscience in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 7 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
8% less funds holding
Funds holding: 37 → 34 (-3)
27% less capital invested
Capital invested by funds: $30.6M → $22.3M (-$8.33M)
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$441K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$267K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$236K |
| 5 |
Renaissance Technologies
New York
|
+$128K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.2M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$169K |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$62.4K |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$57.9K |
| 5 |
Goldman Sachs
New York
|
-$45K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $11K | +$1.28K | +4 | +10% |
|
27
Bank of America
Charlotte,
North Carolina
| $8K | -$28.5K | -89 | -74% |
|
|
BG
28
BlackRock Group
London,
United Kingdom
| $8K | – | – | – |
|
29
Morgan Stanley
New York
| $7K | -$21.8K | -68 | -73% |
|
|
BIM
30
BlackRock Investment Management
Wilmington,
Delaware
| $6K | -$1.6K | -5 | -17% |
|
|
TRCT
31
Tower Research Capital (TRC)
New York
| $6K | +$7.04K | +22 | +2,200% |
|
32
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $4K | – | – | – |
|
|
BIT
33
BlackRock Institutional Trust
San Francisco,
California
| – | -$169K | -519 | Closed |
|
|
34
Goldman Sachs
New York
| – | -$45K | -139 | Closed |
|
|
TC
35
TFS Capital
West Chester,
Pennsylvania
| – | -$43K | -132 | Closed |
|
|
BJ
36
BlackRock Japan
Tokyo,
Japan
| – | -$12K | -38 | Closed |
|
|
DLHL
37
Donald L. Hagan LLC
Sarasota,
Florida
| – | -$11K | -33 | Closed |
|
38
Citigroup
New York
| – | -$3K | -9 | Closed |
|
|
CG
39
Cutler Group
San Francisco,
California
| – | -$2K | -8 | Closed |
|
DARE Hedge Fund Activity: Q2 2016 in Review
34 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q2 2016, worth a combined $22.3M — down 27% from $30.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of DARE and 4 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 7 added.
The largest buyer was Sphera Funds Management, opening a new position worth an estimated $1.2M. The largest seller was Fidelity Investments, cutting an estimated $4.2M.
- 34 institutional investors held Dare Bioscience (DARE) as of Q2 2016, down from 37 in Q1 2016.
- Funds reported $22.3M of Dare Bioscience stock for Q2 2016, down 27% quarter-over-quarter.
- 4 funds opened new Dare Bioscience positions in Q2 2016 and 7 closed out, a net change of -3 holders.
- The largest Dare Bioscience buyer in Q2 2016 was Sphera Funds Management, an estimated $1.2M added.
- The largest Dare Bioscience seller in Q2 2016 was Fidelity Investments, an estimated $4.2M sold.
Based on aggregated 13F filings for Q2 2016.